A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands. (Q33642692)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

0 references

prostate cancer screening

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Fritz H. Schröder

8

object named as

F H Schröder

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

A Gupta

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

C J Savage

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

M Peltola

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

K Pettersson

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

P T Scardino

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

0 references

publication date

27 July 2010

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

103

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

708-714

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

An updated catalog of prostate cancer predictive tools

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

A novel nomogram to predict the probability of prostate cancer on repeat biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

Saturation technique does not decrease cancer detection during followup after initial prostate biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

Development and external validation of an extended repeat biopsy nomogram

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

Validation of a nomogram for predicting positive repeat biopsy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

A Nomogram For Predicting a Positive Repeat Prostate Biopsy in Patients With a Previous Negative Biopsy Session

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

Analysis of repeated biopsy results within 1 year after a noncancer diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: who should undergo a repeat biopsy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938258

21 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605815

21 January 2018

A graphical device to represent the outcomes of a logistic regression analysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605815

21 January 2018

The effect of prostate volume on the yield of needle biopsy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605815

21 January 2018

A comparison of first and repeat (four years later) prostate cancer screening in a randomized cohort of a symptomatic men aged 55-75 years using a biopsy indication of 3.0 ng/ml (results of ERSPC, Rotterdam).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605815

21 January 2018

Eleven-year outcome of patients with prostate cancers diagnosed during screening after initial negative sextant biopsies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605815

21 January 2018

Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605815

21 January 2018

Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab')2 fragments.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605815

21 January 2018

High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605815

21 January 2018

Prostate-Specific Antigen Density Predicts Adverse Pathology and Increased Risk of Biochemical Failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664589

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate cancer detection and tumor characteristics in men with multiple biopsy sessions

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664589

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664589

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664589

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6605815

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664589%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33642692&oldid=2252357815"